Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience

INTRODUCTION: The prevalence of epilepsy increases in elderly patients aged > 65 years, and treatment is challenging because clinical data are limited. OBJECTIVE: Our objective was to evaluate the safety of eslicarbazepine acetate (ESL) in patients aged ≥ 65 years versus non-elderly patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Magalhães, Luís M., Costa, Raquel, Vieira, Mariana, Moreira, Joana, Gama, Helena, Soares-da-Silva, Patrício
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473370/
https://www.ncbi.nlm.nih.gov/pubmed/34536187
http://dx.doi.org/10.1007/s40264-021-01097-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473370/
https://www.ncbi.nlm.nih.gov/pubmed/34536187
http://dx.doi.org/10.1007/s40264-021-01097-5

Ejemplares similares